PDF icon Download PDF
J Knee Surg
DOI: 10.1055/a-2632-2488
Original Article

Serum and Urine Biomarkers Can Predict Outcomes after Osteochondral Allograft Transplantation in the Knee

James L. Cook 
1   Mizzou Joint Preservation Center & Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, Department of Orthopaedic Surgery, University of Missouri. Columbia, Missouri
,
Aaron M. Stoker 
1   Mizzou Joint Preservation Center & Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, Department of Orthopaedic Surgery, University of Missouri. Columbia, Missouri
,
Kylee Rucinski 
1   Mizzou Joint Preservation Center & Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, Department of Orthopaedic Surgery, University of Missouri. Columbia, Missouri
,
James P. Stannard 
1   Mizzou Joint Preservation Center & Thompson Laboratory for Regenerative Orthopaedics, Missouri Orthopaedic Institute, Department of Orthopaedic Surgery, University of Missouri. Columbia, Missouri
› Author Affiliations
Funding None.
› Further Information
   Permissions and Reprints
Preview

Abstract

Osteochondral allograft transplantation (OCAT) is safe and effective for the treatment of large articular defects in the knee. Yet, there are no quantitative methods for predicting OCAT outcomes. This study was designed to analyze serum and urine biomarkers collected prior to OCAT to determine their capabilities for predicting outcomes with respect to functional graft survival. Prospectively collected data for patients undergoing primary multisurface knee OCAT, enrolled in an outcomes registry, were analyzed for graft survival. Blood and urine samples were collected prior to surgery for biomarker analyses. Biomarker concentrations were analyzed for the capability to predict OCAT failures (revision or arthroplasty) that occurred within the first 2 years. Fifty consecutive patients were included for analysis; the 2-year graft survival (success) rate was 80%. In samples obtained prior to OCAT, concentrations of serum hyaluronan (HA) and urine cross-linked C-telopeptide of type II collagen (CTX-II) were significantly higher for failure patients. A urinary biomarker panel containing cross-linked C-telopeptide of type I collagen (CTX-I), CTX-II, HA, IL-8, MMP-2, MMP-3, MMP-13, osteoprotegrin (OPG), and osteopontin (OPN) was able to predict the likelihood of treatment failure with an area under the curve (AUC) of 0.895, sensitivity of 85.3%, and specificity of 93.8%. Preoperative concentrations of urine CTX-II and urine MMP-3 were significantly associated with a higher risk for OCAT treatment failure. Serum and urine protein biomarkers analyzed prior to surgery have the potential to predict functional graft survival at 2 years following complex multisurface OCAT surgery in the knee. With further validation, these biomarkers may be useful as a component of the shared decision-making process for patients and health care teams to evaluate this treatment option. Level of Evidence 2, prospective cohort study.

Keywords

knee - osteochondral allograft transplantation - biomarkers - shared decision-making process - graft survival

Ethical Statement

This study was conducted under approval by the University of Missouri's Institutional Review Board (#2002628).




Publication History

Received: 02 June 2025

Accepted: 10 June 2025

Accepted Manuscript online:
11 June 2025

Article published online:
27 June 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Cook JL, Rucinski K, Crecelius C, Fenkell B, Stannard JP. Assessment of outcomes after multisurface osteochondral allograft transplantations in the knee. Orthop J Sports Med 2022; 10 (06) 23 259671221102452
    CrossrefPubMedSearch in Google Scholar
  • 2 Cook JL, Rucinski K, Crecelius CR, Stannard JP. Initial outcomes after unicompartmental tibiofemoral bipolar osteochondral and meniscal allograft transplantation in the knee using MOPS-preserved fresh (viable) tissues. Am J Sports Med 2023; 51 (03) 596-604
    CrossrefPubMedSearch in Google Scholar
  • 3 Familiari F, Cinque ME, Chahla J. et al. Clinical outcomes and failure rates of osteochondral allograft transplantation in the knee: A systematic review. Am J Sports Med 2018; 46 (14) 3541-3549
    CrossrefPubMedSearch in Google Scholar
  • 4 Gross AE, Kim W, Las Heras F, Backstein D, Safir O, Pritzker KPH. Fresh osteochondral allografts for posttraumatic knee defects: long-term followup. Clin Orthop Relat Res 2008; 466 (08) 1863-1870
    CrossrefPubMedSearch in Google Scholar
  • 5 Cook JL, Rucinski K, Crecelius CR, Kfuri M, Stannard JP. Treatment failures (revision or arthroplasty) after knee osteochondral allograft transplantation with minimum two-year follow-up. Knee 2024; 46: 128-135
    CrossrefPubMedSearch in Google Scholar
  • 6 Kunze KN, Ramkumar PN, Manzi JE, Wright-Chisem J, Nwachukwu BU, Williams III RJ. Risk factors for failure after osteochondral allograft transplantation of the knee: A systematic review and exploratory meta-analysis. Am J Sports Med 2023; 51 (05) 1356-1367
    CrossrefPubMedSearch in Google Scholar
  • 7 Rucinski K, Cook JL, Crecelius CR, Stucky R, Stannard JP. Effects of compliance with procedure-specific postoperative rehabilitation protocols on initial outcomes after osteochondral and meniscal allograft transplantation in the knee. Orthop J Sports Med 2019; 7 (11) 2325967119884291
    CrossrefPubMedSearch in Google Scholar
  • 8 Luk J, Stoker AM, Teixeiro E. et al. Systematic review of osteochondral allograft transplant immunology: How we can further optimize outcomes. J Knee Surg 2021; 34 (01) 30-38
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Ewing MA, Stoker AM, Leary EV. et al. Treatment-monitoring capabilities of serum and urine biomarkers for meniscal allograft transplantation in a preclinical canine model. Am J Sports Med 2022; 50 (10) 2714-2721
    CrossrefPubMedSearch in Google Scholar
  • 10 Kraus VB, Collins JE, Hargrove D. et al.; OA Biomarkers Consortium. Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium. Ann Rheum Dis 2017; 76 (01) 186-195
    CrossrefPubMedSearch in Google Scholar
  • 11 Goode AP, Marshall SW, Kraus VB. et al. Association between serum and urine biomarkers and lumbar spine individual radiographic features: the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage 2012; 20 (11) 1286-1293
    PubMedSearch in Google Scholar
  • 12 Wolfe PN, Stoker AM, Leary E, Crist BD, Bozynski CC, Cook JL. Evaluation of serum and urine biomarker panels for developmental dysplasia of the hip prior to onset of secondary osteoarthritis. Cartilage 2024; 15 (02) 164-174
    CrossrefPubMedSearch in Google Scholar
  • 13 Kalogera S, Jansen MP, Bay-Jensen AC. et al. Relevance of biomarkers in serum vs. synovial fluid in patients with knee osteoarthritis. Int J Mol Sci 2023; 24 (11) 9483
    PubMedSearch in Google Scholar
  • 14 Lineham B, Altaie A, Harwood P, McGonagle D, Pandit H, Jones E. A systematic review on the potential value of synovial fluid biomarkers to predict clinical outcomes in cartilage repair treatments. Osteoarthritis Cartilage 2022; 30 (08) 1035-1049
    PubMedSearch in Google Scholar
  • 15 Werner NC, Stoker AM, Bozynski CC, Keeney JA, Cook JL. Characterizing correlations among disease severity measures in osteochondral tissues from osteoarthritic knees. J Orthop Res 2021; 39 (05) 1103-1112
    PubMedSearch in Google Scholar
  • 16 Roller BL, Monibi F, Stoker AM, Bal BS, Cook JL. Identification of novel synovial fluid biomarkers associated with meniscal pathology. J Knee Surg 2016; 29 (01) 47-62
    PubMedSearch in Google Scholar
  • 17 Monibi F, Roller BL, Stoker A, Garner B, Bal S, Cook JL. Identification of synovial fluid biomarkers for knee osteoarthritis and correlation with radiographic assessment. J Knee Surg 2016; 29 (03) 242-247
    PubMedSearch in Google Scholar
  • 18 Cook JL, Stoker AM, Stannard JP. et al. A novel system improves preservation of osteochondral allografts. Clin Orthop Relat Res 2014; 472 (11) 3404-3414
    CrossrefPubMedSearch in Google Scholar
  • 19 Stoker AM, Stannard JP, Cook JL. Chondrocyte viability at time of transplantation for osteochondral allografts preserved by the Missouri Osteochondral Preservation System versus standard tissue bank protocol. J Knee Surg 2018; 31 (08) 772-780
    Thieme ConnectPubMedSearch in Google Scholar
  • 20 Oladeji LO, Stannard JP, Cook CR. et al. Effects of autogenous bone marrow aspirate concentrate on radiographic integration of femoral condylar osteochondral allografts. Am J Sports Med 2017; 45 (12) 2797-2803
    CrossrefPubMedSearch in Google Scholar
  • 21 Stannard JP, Cook JL. Prospective assessment of outcomes after primary unipolar, multisurface, and bipolar osteochondral allograft transplantations in the knee: A comparison of 2 preservation methods. Am J Sports Med 2020; 48 (06) 1356-1364
    CrossrefPubMedSearch in Google Scholar
  • 22 Schreiner AJ, Stannard JP, Cook CR. et al. Initial clinical outcomes comparing frozen versus fresh meniscus allograft transplants. Knee 2020; 27 (06) 1811-1820
    CrossrefPubMedSearch in Google Scholar
  • 23 Zitsch BP, Stannard JP, Worley JR, Cook JL, Leary EV. Patient-reported outcomes for large bipolar osteochondral allograft transplantation in combination with realignment osteotomies for the knee. J Knee Surg 2021; 34 (11) 1260-1266
    Thieme ConnectPubMedSearch in Google Scholar
  • 24 Buyuk AF, Stannard JP, Rucinski K, Crecelius CR, Cook JL. The Missouri Osteochondral Preservation System is associated with better short-term outcomes than standard preservation methods when performing osteochondral allograft transplantation using shell grafts for patellofemoral lesions. Arthroscopy 2023; 39 (03) 650-659
    CrossrefPubMedSearch in Google Scholar
  • 25 Rucinski K, Stucky R, Crecelius CR, Stannard JP, Cook JL. Effects of patient assessment and education by an integrated care team on postoperative adherence and failure rates after osteochondral allograft and meniscal allograft transplantation in the knee. Orthop J Sports Med 2023; 11 (05) 23 259671231160780
    CrossrefPubMedSearch in Google Scholar
  • 26 Boonstra AM, Schiphorst Preuper HR, Reneman MF, Posthumus JB, Stewart RE. Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. Int J Rehabil Res 2008; 31 (02) 165-169
    CrossrefPubMedSearch in Google Scholar
  • 27 Martin RL, Kivlan BR, Christoforetti JJ. et al. Minimal clinically important difference and substantial clinical benefit values for a pain visual analog scale after hip arthroscopy. Arthroscopy 2019; 35 (07) 2064-2069
    PubMedSearch in Google Scholar
  • 28 Higgins LD, Taylor MK, Park D. et al.; International Knee Documentation Committee. Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form. Joint Bone Spine 2007; 74 (06) 594-599
    CrossrefPubMedSearch in Google Scholar
  • 29 O'Connor CM, Ring D. Correlation of Single Assessment Numeric Evaluation (SANE) with other patient reported outcome measures (PROMs). Arch Bone Jt Surg 2019; 7 (04) 303-306
    PubMedSearch in Google Scholar
  • 30 Christensen J, Peters C, Gililland J, Stoddard G, Pelt C. Physical activity, pain interference and comorbidities relate to PROMIS physical function in younger adults following total knee arthroplasty. Disabil Rehabil 2021; 43 (26) 3741-3747
    PubMedSearch in Google Scholar
  • 31 Hays RD, Schalet BD, Spritzer KL, Cella D. Two-item PROMIS® global physical and mental health scales. J Patient Rep Outcomes 2017; 1 (01) 2
    PubMedSearch in Google Scholar
  • 32 Coppelman EB, David FH, Tóth F, Ernst NS, Trumble TN. The association between collagen and bone biomarkers and radiographic osteoarthritis in the distal tarsal joints of horses. Equine Vet J 2020; 52 (03) 391-398
    CrossrefPubMedSearch in Google Scholar
  • 33 Hurvich CM, Simonoff JS, Tsai CL. Smoothing parameter selection in nonparametric regression using an improved Akaike Information Criterion. J R Stat Soc B 1998; 60: 271-293
    PubMedSearch in Google Scholar
  • 34 Palà E, Bustamante A, Pagola J. et al. Blood-based biomarkers to search for atrial fibrillation in high-risk asymptomatic individuals and cryptogenic stroke patients. Front Cardiovasc Med 2022; 9: 908053
    PubMedSearch in Google Scholar
  • 35 Burland JP, Hunt ER, Lattermann C. Serum biomarkers in healthy, injured, and osteoarthritic knees: A critical review. J Cartil Jt Preserv 2023; 3 (02) 100091
    PubMedSearch in Google Scholar
  • 36 Herrero-Manley L, Alabajos-Cea A, Suso-Martí L. et al. Serum lipid biomarkers and inflammatory cytokines associated with onset and clinical status of patients with early knee osteoarthritis. Front Nutr 2023; 10: 1126796
    PubMedSearch in Google Scholar
  • 37 Kwan Tat S, Lajeunesse D, Pelletier JP, Martel-Pelletier J. Targeting subchondral bone for treating osteoarthritis: what is the evidence?. Best Pract Res Clin Rheumatol 2010; 24 (01) 51-70
    PubMedSearch in Google Scholar
  • 38 Hardy E, Fernandez-Patron C. Destroy to rebuild: The connection between bone tissue remodeling and matrix metalloproteinases. Front Physiol 2020; 11: 47
    CrossrefPubMedSearch in Google Scholar
  • 39 Braaten JA, Banovetz MT, DePhillipo NN. et al. Biomarkers for osteoarthritis diseases. Life (Basel) 2022; 12 (11) 1799
    PubMedSearch in Google Scholar
  • 40 Henrotin Y, Sanchez C, Bay-Jensen AC, Mobasheri A. Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives. Ann Phys Rehabil Med 2016; 59 (03) 145-148
    PubMedSearch in Google Scholar
  • 41 De Roover A, Escribano-Núñez A, Monteagudo S, Lories R. Fundamentals of osteoarthritis: Inflammatory mediators in osteoarthritis. Osteoarthritis Cartilage 2023; 31 (10) 1303-1311
    PubMedSearch in Google Scholar
  • 42 Ruan G, Xu J, Wang K. et al. Associations between serum IL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis. Clin Rheumatol 2019; 38 (12) 3609-3617
    PubMedSearch in Google Scholar
  • 43 Leong DJ, Hardin JA, Cobelli NJ, Sun HB. Mechanotransduction and cartilage integrity. Ann N Y Acad Sci 2011; 1240: 32-37
    PubMedSearch in Google Scholar
  • 44 Wolfe PN, Stoker AM, Crist BD, Leary E, Bozynski CC, Cook JL. Evaluation of mechanistic serum and urine biomarkers for secondary osteoarthritis associated with developmental dysplasia of the hip. J Orthop 2023; 42: 24-29
    CrossrefPubMedSearch in Google Scholar
  • 45 Rucinski K, Leary E, Royse LA. Factors important to patients when making treatment decisions for knee osteoarthritis. J Knee Surg 2023; 36 (14) 1413-1421
    PubMedSearch in Google Scholar